Coordinated patterns of genomic instability and immunogenicity predict 10-year breast cancer progression across subtypes and patient characteristics

Abstract Genomic instability is associated with breast cancer immune response. We sought to evaluate joint effects of genomic instability and immune response on recurrence using validated RNA-based assays and statistical models for assessing joint expression in a population-based dataset ( N = 2783). Prognostic value of the resulting coordinated signature, Repair, Immune, and Genomics for Oncologic Reclassification (RIGOR150), was assessed in estrogen receptor (ER)+ and ER− breast cancers ( N = 1899 with recurrence information) and validated in public datasets. RIGOR150 was strongly associated with recurrence risk in training (Hazard Ratio [HR] for high vs. low-risk = 5.10, 95% confidence interval [CI] = 3.19, 8.15) and test data (HR = 3.07, 95% CI = 1.73, 5.45) and was validated in external datasets. Among ER+ tumors, RIGOR150 high-risk was associated with early (0–5 years, HR = 5.75, 95% CI = 3.38, 9.77) and late recurrence (5–10 years, HR = 2.67, 95% CI = 1.26, 5.65). RIGOR150 added prognostic value independent of existing risk predictors (21-gene recurrence score and PAM50), and was associated with neoantigens, proliferation, and tumor-immune cell proximity. Overall, joint patterns of genomic instability and immunogenicity augment current breast cancer prognostic scores, providing early and late prognostication.

Authors

Institutions

Publication Details

Journal
npj Breast Cancer
Published
2026-11-13
DOI
https://doi.org/10.1038/s41523-026-01078-w
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Coordinated patterns of genomic instability and immunogenicity predict 10-year breast cancer progression across subtypes and patient characteristics

Katherine A. Hoadley, Sarah C. Van Alsten, Melissa A. Troester, Alyssa Joy Cozzo et al.
npj Breast Cancer
Breast Cancer Treatment Studies
article

Coordinated patterns of genomic instability and immunogenicity predict 10-year breast cancer progression across subtypes and patient characteristics

Katherine A. Hoadley, Sarah C. Van Alsten, Melissa A. Troester, Alyssa Joy Cozzo, Erin L. Kirk, Qichen Wang, Andrew Edward Walker, Xiaohua Gao, J. S. Marron
article en

Abstract

Abstract Genomic instability is associated with breast cancer immune response. We sought to evaluate joint effects of genomic instability and immune response on recurrence using validated RNA-based assays and statistical models for assessing joint expression in a population-based dataset ( N = 2783). Prognostic value of the resulting coordinated signature, Repair, Immune, and Genomics for Oncologic Reclassification (RIGOR150), was assessed in estrogen receptor (ER)+ and ER− breast cancers ( N = 1899 with recurrence information) and validated in public datasets. RIGOR150 was strongly associated with recurrence risk in training (Hazard Ratio [HR] for high vs. low-risk = 5.10, 95% confidence interval [CI] = 3.19, 8.15) and test data (HR = 3.07, 95% CI = 1.73, 5.45) and was validated in external datasets. Among ER+ tumors, RIGOR150 high-risk was associated with early (0–5 years, HR = 5.75, 95% CI = 3.38, 9.77) and late recurrence (5–10 years, HR = 2.67, 95% CI = 1.26, 5.65). RIGOR150 added prognostic value independent of existing risk predictors (21-gene recurrence score and PAM50), and was associated with neoantigens, proliferation, and tumor-immune cell proximity. Overall, joint patterns of genomic instability and immunogenicity augment current breast cancer prognostic scores, providing early and late prognostication.

npj Breast Cancer
University of North Carolina at Chapel Hill (US), UNC Lineberger Comprehensive Cancer Center (US)
U.S. Department of Defense, Breast Cancer Research Foundation, North Carolina Department of Health and Human Services, Susan G. Komen North Carolina, Susan G. Komen, National Institutes of Health, National Cancer Institute, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Good health and well-being
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon